Predicting Slow Walking Speed From a Pooled Cohort Analysis: Sarcopenia Definitions, Agreement, and Prevalence in Australia and New Zealand
Open Access
- 10 July 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 78 (12) , 2415-2425
Abstract
Background: Recent operational definitions of sarcopenia have not been replicated and compared in Australia and New Zealand (ANZ) populations. We aimed to identify sarcopenia measures that discriminate ANZ adults with slow walking speed (<0.8 m/s) and determine the agreement between the Sarcopenia Definitions and Outcomes Consortium (SDOC) and revised European Working Group for Sarcopenia in Older People (EWGSOP2) operational definitions of sarcopenia. Methods: Eight studies comprising 8 100 ANZ community-dwelling adults (mean age ± standard deviation, 62.0 ± 14.4 years) with walking speed, grip strength (GR), and lean mass data were combined. Replicating the SDOC methodology, 15 candidate variables were included in sex-stratified classification and regression tree models and receiver operating characteristic curves on a pooled cohort with complete data to identify variables and cut points discriminating slow walking speed (<0.8 m/s). Agreement and prevalence estimates were compared using Cohen’s Kappa (CK). Results: Receiver operating characteristic curves identified GR as the strongest variable for discriminating slow from normal walking speed in women (GR <20.50 kg, area under curve [AUC] = 0.68) and men (GR <31.05 kg, AUC = 0.64). Near-perfect agreement was found between the derived ANZ cut points and SDOC cut points (CK 0.8–1.0). Sarcopenia prevalence ranged from 1.5% (EWGSOP2) to 37.2% (SDOC) in women and 1.0% (EWGSOP2) to 9.1% (SDOC) in men, with no agreement (CK <0.2) between EWGSOP2 and SDOC. Conclusions: Grip strength is the primary discriminating characteristic for slow walking speed in ANZ women and men, consistent with findings from the SDOC. Sarcopenia Definitions and Outcomes Consortium and EWGSOP2 definitions showed no agreement suggesting these proposed definitions measure different characteristics and identify people with sarcopenia differently.Keywords
Funding Information
- Australian National Health and Medical Research Council (GNT1174886)
- Australian Medical Research Future (APP2005987)
- NHMRC (APP1162867)
- MRFF (APP1199726)
- Deakin University
- Amgen
This publication has 58 references indexed in Scilit:
- Sarcopenia in Asia: Consensus Report of the Asian Working Group for SarcopeniaJournal of the American Medical Directors Association, 2014
- Adiposity, Muscle Mass, and Muscle Strength in Relation to Functional Decline in Older PersonsEpidemiologic Reviews, 2012
- Evaluation of a Peer-Led Falls Prevention Program for Older AdultsArchives of Physical Medicine and Rehabilitation, 2011
- Sarcopenia With Limited Mobility: An International ConsensusJournal of the American Medical Directors Association, 2011
- Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on SarcopeniaJournal of the American Medical Directors Association, 2011
- Gait Speed and Survival in Older AdultsJAMA, 2011
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Trials and tribulations of recruiting 2,000 older women onto a clinical trial investigating falls and fractures: Vital D studyBMC Medical Research Methodology, 2009
- Cohort Profile: The North West Adelaide Health Study (NWAHS)International Journal of Epidemiology, 2008
- Factors associated with hip cartilage volume measured by magnetic resonance imaging: The Tasmanian Older Adult Cohort StudyArthritis & Rheumatism, 2005